#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma Alpha-1 antitrypsin deficiency Congenital absence of bile ducts Pancreatic neuroendocrine tumour Hereditary ataxia Malignant fibrous histiocytoma Severe myoclonic epilepsy of infancy Dementia Mastocytosis Meningitis meningococcal Piriformis syndrome Gaucher's disease type I Mucopolysaccharidosis II Ocular myasthenia Neovascular age-related macular degeneration More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Diagnostics Arterial tortuosity syndrome – Life with Disease Leukoencephalopathy Breast angiosarcoma Cystic fibrosis – Trials in Disease Synovial sarcoma recurrent – Trials in Disease Hereditary motor and sensory neuropathy – Trials in Disease Hepatoblastoma – Trials in Disease Haemophagocytic lymphohistiocytosis – Diagnostics Alport’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sulfur Hexafluoride Sildenafil (-)-PHENSERINE TARTRATE Pitolisant Esk-001 TRONTINEMAB Glutathione PIROXICAM Tisagenlecleucel Magnesium Oxide, Light Somatostatin SODIUM FUSIDATE Phenol 6QC-ICG Sabirnetug Isavuconazonium Sulfate Bomedemstat Melphalan Interleukin-1 Omo-103 More therapies…

    Learn about Your Condition

    Dermatomyositis Hypochromic anaemia Cystic fibrosis Brain neoplasm malignant Organ donor Oesophagogastroscopy Arrhythmia Merycism Hyperkalaemia Congenital myopathy Alopecia areata Alcoholic liver disease Blood iron increased Tricuspid valve disease B-cell type acute leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Idiopathic pulmonary fibrosis

  • Study on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Treprostinil
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Bi 1819479
    Austria Belgium Czechia Denmark Finland France +8

  • Study on the Effects and Safety of Buloxibutid for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Buloxibutid
    Austria Belgium Germany Greece Italy Poland

  • Study on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    4 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Bexotegrast
    Belgium Czechia Denmark France Germany Greece +5

  • Study on the Effectiveness and Safety of LTP001 for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Ltp001
    Czechia Germany The Netherlands Poland

  • Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Axatilimab
    Belgium Czechia France Germany Italy Poland +2
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!